πŸ‡ΊπŸ‡Έ FDA
Patent

US 8828429

Release-control composition

granted A61KA61K31/4164A61K31/4188

Quick answer

US patent 8828429 (Release-control composition) held by Takeda Pharmaceutical Company Limited expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/4164, A61K31/4188, A61K9/4816, A61K9/4866